Global Biobanks Market: Overview
Technological advancements, introduction of innovative methods, and massive population base of the emerging economies such as China and India, will present substantial opportunities to the global market for biobanks.
A biobank is a storage bank for biological samples, such as blood, DNA, human tissue, that are used for medical research purposes, in order to find new treatments for diseases. Biobanks play a significant role in biomedical research. They aid in the determination of the general and unique features of the continuous cell line and whether contaminants are present or not, thereby aiding in the analysis of the raw materials from which a biological product is derived. The genetic and other traits such as gender, age, ethnicity, and blood type of the specimens are catalogued by a biobank. The was pegged at USD 142 mn in 2011. It is expected to grow at a CAGR of 5.4% during the forecast period 2011-2018, attaining a revenue worth USD 216.3 mn by the end of 2018.
Request Brochure of the Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=576
Â Global Biobanks Market: Drivers and Restraints
As biobanks help in providing personalized medications and minimizing drug side effects, thereby improving the overall health of patients suffering from various diseases, the demand for biobanks will augment worldwide. Some of the key factors driving the market for biobanks are advancement in drug discovery, rising prevalence of chronic disorders such as cancer, respiratory disorders, and cardiovascular diseases, increasing healthcare expenditure, and several government initiatives supporting the development of biobanks. Another growth driver of the global biobanks market is the gradual propagation of awareness about biobanks and their significance. A number of biotechnology and pharmaceutical companies have been using biobanks for developing new drugs, urging the growth of the global biobanks market.
Global Biobanks Market: Regional Analysis
Based on geography, the global market for biobanks can be segmented into Europe, North America, Asia Pacific, and the Rest of the World. North America presently leads the global market for biobanks, closely followed by Europe. The prominence of these regions can be attributed to the increasing incidence of chronic diseases, the imperative need to find effective treatments for them, large amounts of government investments in the area of biobanks, and growing number of research activities, together with drug discovery in the region.